Citation Impact
Citing Papers
Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer
2007
Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization
2010
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Urine markers for detection and surveillance of bladder cancer
2013
Defining the role of NMP22 in bladder cancer surveillance
2007
Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma
2008
Antimetastatic activity of Sulforaphane
2006
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors
2003
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
2010
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
The bladder extracellular matrix. Part I: architecture, development and disease
2009
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Bladder cancer biomarkers: current developments and future implementation
2007
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Diagnosis of urothelial carcinoma from urine
2009
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
2008
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
2012
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
2005
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Updated assessment of neoblader utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort
2013
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma
2010
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
2015
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology
2014
Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
2010
ROS signalling in the biology of cancer
2017 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Urinary Markers in Bladder Cancer
2007
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder
2011
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
2009
Comparative impact of continent and incontinent urinary diversion on long‐term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a
2015
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
2012
Ratiometric Fluorescent Biosensor for Hyaluronidase with Hyaluronan As Both Nanoparticle Scaffold and Substrate for Enzymatic Reaction
2014
Cytology and Urinary Markers for the Diagnosis of Bladder Cancer
2009
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
2009
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
The Interleukin-8 Pathway in Cancer
2008 Standout
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline
2017
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
2009
Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease
2008
The MicroRNA Spectrum in 12 Body Fluids
2010 Standout
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
2003
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
2012
Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy ( RC ) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer
2017
Chemical Glycoproteomics
2016 StandoutNobel
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of S. Hautmann being referenced
Detection and Characterization of Early Prostate Cancer by Six Systematic Biopsies and Fine Needle Aspiration Cytology in Prostates from Bladder Cancer Patients
2001
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
HAS1 expression in bladder cancer and its relation to urinary HA test
2007
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
2005
High-Grade Prostatic Intraepithelial Neoplasia in Cystoprostatectomy Specimens
2001
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests
2002
Immunocyt and the HA-HAase Urine Tests for the Detection of Bladder Cancer: A Side-by-Side Comparison
2004
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
Recovery of erectile function after nerve‐sparing radical prostatectomy: improvement with nightly low‐dose sildenafil
2008
A SIDE BY SIDE COMPARISON OF CYTOLOGY AND BIOMARKERS FOR BLADDER CANCER DETECTION
2004
Local intratumor immunotherapy of prostate cancer with interleukin-2 reduces tumor growth.
1999
Clinical use of Urinary Markers For The Detection And Prognosis Of Bladder Carcinoma: A Comparison Of Immunocytology With Monoclonal Antibodies Against Lewis X And 486p3/12 With The BTA STAT And NMP22 Tests
2002
ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCER
2001